A Non-Interventional Multi-Database Post-Authorisation Study to Assess Pregnancy-Related Safety Data from Women with Severe Asthma Exposed to Tezepelumab (TREATY)

29/05/2024
04/07/2025
EU PAS number:
EUPAS1000000176
Study
Planned
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

D5180R00010 PASS Protocol v3.0_Redacted.pdf

English (2.29 MB - PDF) View document
Study results
Study report
Study report

EUPAS1000000176_First Progress Report v1.0_Redacted.pdf

English (475.73 KB - PDF) View document
Other information